Keyphrases
C57BL
25%
Celecoxib
50%
COX-2 Inhibition
25%
Cyclooxygenase-2 Inhibitors
25%
Day 14
50%
EP Receptors
75%
EP3 Receptor
100%
Knock-in Mouse Model
75%
Lung Cells
25%
Lymphangiogenesis
25%
Lymphatic Endothelial Cells
25%
MRNA Expression
25%
Novel Therapeutics
25%
Podoplanin
50%
Prostaglandin E
25%
Prostaglandin E2
50%
Prostaglandins
100%
Receptor Knockout
75%
Receptor Signaling
100%
Signaling Pathway
25%
Stromal Tissue
100%
Subcutaneous Injection
25%
Tumor
75%
Tumor Angiogenesis
25%
Tumor Development
25%
Tumor Growth
25%
Tumor Implantation
25%
Tumor Size
25%
Tumor Tissue
25%
Tumor Weight
25%
Tumor-associated Lymphangiogenesis
100%
Vascular Endothelial Growth Factor receptor-3
100%
Vascular Endothelial Growth factor-C (VEGF-C)
50%
Medicine and Dentistry
C57BL/6
12%
Celecoxib
25%
Cell Signaling Pathway
12%
Cyclooxygenase 2 Inhibitor
12%
Endothelial Cell
12%
Lung
12%
Lymph Duct
12%
Lymphangiogenesis
100%
Messenger RNA
12%
Neoplasm
100%
Podoplanin
25%
Prostaglandin E
12%
Prostaglandin E Receptor 3
100%
Prostaglandin E2
25%
Receptor
87%
Stromal Tumor
37%
Subcutaneous Injection
12%
Tumor Angiogenesis
12%
Tumor Cell Inoculation
12%
Tumor Progression
12%
Vasculotropin C
25%
Vasculotropin Receptor 3
50%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
20%
C57BL 6 Mouse
20%
Celecoxib
40%
COX-2 Inhibitor
20%
Knockout Mouse
60%
Lymphangiogenesis
100%
Messenger RNA
20%
Prostaglandin E
20%
Prostaglandin E Receptor 3
100%
Prostaglandin E2
40%
Tumor Cell Inoculation
20%
Tumor Progression
20%
Tumor Volume
20%
Vascular Endothelial Growth Factor
40%
VEGF Receptors
80%
Wild Type
40%
Immunology and Microbiology
Angiogenesis
20%
C57BL 6 Mouse
20%
Cyclooxygenase
20%
Knockout Mouse
60%
Lymphangiogenesis
100%
Prostaglandin
100%
Prostaglandin E
20%
Prostaglandin E2
40%
Tumor Cell Inoculation
20%
Tumor Volume
20%
Vasculotropin
80%
Vasculotropin C
40%
Wild Type
40%
Neuroscience
Angiogenesis
14%
Celecoxib
28%
COX-2 Inhibitor
14%
Lymphangiogenesis
100%
Messenger RNA
14%
Podoplanin
28%
Prostaglandin E
14%
Prostaglandin E Receptor 3
100%
Prostaglandin E2
28%
Receptor
100%
Vasculotropin C
28%
Vasculotropin Receptor 3
57%
Pharmacology, Toxicology and Pharmaceutical Science
C57BL 6 Mouse
8%
Celecoxib
16%
COX-2 Inhibitor
8%
Knockout Mouse
25%
Messenger RNA
8%
Neoplasm
100%
Podoplanin
16%
Prostaglandin E
8%
Prostaglandin E Receptor 3
100%
Prostaglandin E2
16%
Receptor
58%
Subcutaneous Injection
8%
Tumor Growth
8%
Vasculotropin C
16%
Vasculotropin Receptor 3
33%